F78.A1

Clinical Causes: Mutations or alterations in the SYNGAP1 gene, which plays a crucial role in synaptic function and neural communication. Inherited genetic factors, though most cases are due to spontaneous mutations with no family history. Potential environmental factors do not directly cause the condition but may influence overall development.

Key Symptoms: Intellectual disability, ranging from mild to severe. Delayed speech and language development. Muscle tone issues, such as hypotonia (reduced muscle strength). Seizures or epileptic episodes in some individuals. Behavioral challenges, including hyperactivity or autistic-like features. Motor coordination difficulties and delays in achieving developmental milestones like crawling and walking. Sensory processing issues, such as hypersensitivity or hyposensitivity to stimuli.

Diagnosis Path: Diagnosis of SYNGAP1-related intellectual disability involves a combination of clinical evaluation and genetic testing. Doctors typically review developmental history, observe behavioral and neurological signs, and perform genetic tests like targeted gene panels or whole-exome sequencing to identify mutations in the SYNGAP1 gene. Early diagnosis is vital for implementing supportive therapies and planning appropriate interventions.

Treatment Protocols: Developmental therapies, such as speech, occupational, and physical therapy to enhance communication skills and motor development. Educational interventions tailored to the child's cognitive abilities and learning needs. Medications to control seizures if they occur. Behavioral therapy to address behavioral challenges and improve social skills. Supportive care for associated symptoms like muscle tone issues or sensory sensitivities. Regular medical monitoring and multidisciplinary care to address evolving needs.